AMC Sinks 7%, Gives Back Part of Sharp Rally; Cinemark and IMAX Dip

AMC stock is bleeding out a big chunk of its prior-session surge while Cinemark and IMAX barely flinch, and that split tells you something important about who is actually driving the selling.

Published September 29, 2026, 12:55pm ET · 2 min read

Market Movers desk. Editor: David Moadel.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A wide shot of a busy AMC movie theater lobby filled with diverse crowds standing in multiple queues. An illuminated pink 'AMC' sign is prominently displayed above several digital movie showtime boards. An escalator is visible on the left, and the floor is light-colored tile. The scene conveys a sense of anticipation and activity.
Movie enthusiasts line up in a bustling AMC theater lobby, reflecting the strong theatrical exhibition rebound as blockbuster preview nights set new records. © Chris Hondros / Getty Images News via Getty Images

Selling is landing hard on AMC Entertainment (NYSE:AMC) stock as the theater chain is giving back part of a sharp rally from the prior session. AMC stock is at $3.05, down 7% in afternoon trading. Meanwhile, the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is down 0.3%, leaving major indexes close to flat and making the AMC pullback stand out even more.

Two other listed theater stocks, Cinemark Holdings (NYSE:CNK) and IMAX (NYSE:IMAX), are slipping only modestly by comparison. Cinemark stock is at $37.92, down 1%, a far smaller pullback than the one weighing on AMC. Similarly, IMAX stock is at $55.23, down 2%, which keeps the losses across the rest of the exhibitor group contained.

That split is the most useful detail in the AMC move. Heavy selling in AMC stock with indexes barely moving points to positioning specific to AMC, while pressure on theater operators as a group stays light. Buying interest was concentrated in AMC during the prior session as well, when the stock outperformed its competitors on a strong trading day.

Profit Taking Follows AMC’s Sharp Run

Profit taking fits the setup, since AMC stock is up 99% year to date (YTD) and a big one-session jump handed shareholders a fresh chance to lock in gains. Cutting tends to hit hardest in the name that ran the most, and AMC matches that description within the theater group after the prior session’s burst of buying interest.

Meanwhile, Cinemark stock is up 5% over the past month, a measured gain next to AMC stock’s much sharper run. IMAX stock has done better, up 10% over the same stretch. Both Cinemark and IMAX shares are posting only modest drops as AMC slips, consistent with the smoother path each stock has taken.

Weighing the Case For and Against AMC

The next test for AMC is the close, which could show how much of the prior session’s rally the stock manages to keep. AMC stock is worth watching for any late return of buying interest, since a firm finish would suggest the profit taking has largely run its course.

A second signal comes from the rest of the theater group. Steady trading in Cinemark and IMAX shares would reinforce the view that the movie-exhibitor recovery remains intact while AMC stock works through its own swing.

Contact [email protected] for any questions or corrections.

David Moadel

David Moadel is financial writer specializing in stocks, ETFs, options, precious metals, and Bitcoin. David has written well over 1,000 articles for leading online publications, helping investors understand markets, income strategies, and risk.His work has appeared in The Motley Fool, InvestorPlace, U.S. News & World Report, TipRanks, ValueWalk, Benzinga, Market Realist, TalkMarkets, Finmasters, 24/7 Wall St., and others.With a master’s degree in education, David has taught at the elementary, high school, and college levels. That teaching background shapes his writing style: clear, educational, and practical. David has also built a loyal social-media audience by providing trustworthy financial content on YouTube, X/Twitter, and StockTwits.

All articles →